We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$90.2M
AUM Growth
-$6.75M
(-7%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-15.42%
Top 10 Holdings %
Top 10 Hldgs %
39%
Holding
124
New
12
Increased
17
Reduced
57
Closed
18
Avg Time Held
2
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$926K |
| 2 |
Pentair
PNR
|
+$778K |
| 3 |
Cerenome
CNSY
|
+$606K |
| 4 |
Veritone
VERI
|
+$556K |
| 5 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$2.06M |
| 2 |
Tactile Systems Technology
TCMD
|
+$1.84M |
| 3 |
NeoGenomics
NEO
|
+$1.68M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.68M |
| 5 |
Ooma
OOMA
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.22% |
| 2 | Industrials | 11.67% |
| 3 | Technology | 10.9% |
| 4 | Financials | 3.3% |
| 5 | Communication Services | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Kimberly-Clark
KMB
$35.1B
| $575K | 0.64% |
4,450
-550
| -11% | -$71.6K |
2014 Q2
12 quarters
|
|
52
DELISTED
Cantaloupe
CTLP
| $566K | 0.63% |
108,850
-150
| -0.1% | -$729 |
2014 Q1
13 quarters
|
|
53
CarParts.com
PRTS
$61M
| $557K | 0.62% |
17,260
-1,665
| -9% | -$56.2K |
2013 Q2
16 quarters
|
|
54
3M
MMM
$85B
| $536K | 0.59% |
3,081
| – | – |
2013 Q2
16 quarters
|
|
55
GSK
GSK
$99.2B
| $513K | 0.57% |
9,520
-960
| -9% | -$51.2K |
2013 Q2
16 quarters
|
|
56
DELISTED
BioTelemetry, Inc.
BEAT
| $502K | 0.56% |
15,000
| – | – |
2015 Q3
7 quarters
|
|
57
Verizon
VZ
$186B
| $499K | 0.55% |
11,180
+350
| +3% | +$16.3K |
2013 Q2
16 quarters
|
|
|
58
Veritone
VERI
$54.9M
| $498K | 0.55% |
+42,500
| New | +$556K |
2017 Q2
0 quarters
|
|
59
DELISTED
Vonage Holdings Corporation
VG
| $454K | 0.5% |
69,450
+31,600
| +83% | +$211K |
2017 Q1
1 quarter
|
|
60
US Physical Therapy
USPH
$1.28B
| $438K | 0.49% |
7,250
| – | – |
2016 Q2
4 quarters
|
|
|
HDP
61
DELISTED
Hortonworks, Inc.
HDP
| $421K | 0.47% |
+32,675
| New | +$392K |
2017 Q2
0 quarters
|
|
62
Xtant Medical Holdings
XTNT
$40.2M
| $419K | 0.46% |
52,925
-4,167
| -7% | -$27.7K |
2015 Q4
6 quarters
|
|
63
Ionis Pharmaceuticals
IONS
$7.14B
| $404K | 0.45% |
7,950
-700
| -8% | -$32.6K |
2013 Q2
16 quarters
|
|
64
US Bancorp
USB
$91.5B
| $398K | 0.44% |
7,662
-1,089
| -12% | -$56.1K |
2013 Q2
16 quarters
|
|
|
CY
65
DELISTED
Cypress Semiconductor
CY
| $380K | 0.42% |
27,875
| – | – |
2013 Q2
16 quarters
|
|
66
DELISTED
Enservco Corp.
ENSV
| $377K | 0.42% |
80,945
| – | – |
2016 Q4
2 quarters
|
|
|
TEAR
67
DELISTED
TearLab Corporation
TEAR
| $377K | 0.42% |
225,589
-11,250
| -5% | -$22.9K |
2015 Q2
8 quarters
|
|
68
Turtle Beach Corp
TBCH
$272M
| $368K | 0.41% |
131,575
| – | – |
2015 Q4
6 quarters
|
|
69
IZEA Worldwide
IZEA
$39.7M
| $353K | 0.39% |
46,084
-1,262
| -3% | -$14.8K |
2016 Q1
5 quarters
|
|
70
Deere & Co
DE
$173B
| $352K | 0.39% |
+2,850
| New | +$334K |
2017 Q2
0 quarters
|
|
71
LifeVantage
LFVN
$75.5M
| $352K | 0.39% |
81,225
| – | – |
2013 Q2
16 quarters
|
|
|
CRZO
72
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $344K | 0.38% |
19,750
-1,200
| -6% | -$27.9K |
2016 Q4
2 quarters
|
|
73
Apple
AAPL
$5.01T
| $341K | 0.38% |
9,480
| – | – |
2016 Q3
3 quarters
|
|
74
Micron Technology
MU
$994B
| $328K | 0.36% |
11,000
| – | – |
2016 Q2
4 quarters
|
|
|
TCF
75
DELISTED
TCF Financial Corporation
TCF
| $303K | 0.34% |
19,000
+2,250
| +13% | +$36.2K |
2017 Q1
1 quarter
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Perkins Capital Management held 124 positions worth $90.2M, down 7% from $96.9M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $13.9M in Q2 2017, closing 18 positions and reducing 57 holdings. Its most notable exit was Tactile Systems Technology, an estimated $1.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 62% a quarter earlier, followed by Industrials and Technology.
Against the trend, Perkins Capital Management opened a new position in Cencora worth $983K.
- Perkins Capital Management's largest Q2 2017 buy was Cencora: 10,400 shares worth $983K.
- Perkins Capital Management added most to Cerenome in Q2 2017, an estimated $606K increase.
- Perkins Capital Management's biggest Q2 2017 reduction was Cardiovascular Systems, Inc., cutting an estimated $2.06M.
- Perkins Capital Management fully exited Tactile Systems Technology in Q2 2017, selling an estimated $1.84M.
- Perkins Capital Management's ten largest holdings make up 39% of its $90.2M portfolio in Q2 2017.
- Perkins Capital Management opened 12 new positions and closed 18 in Q2 2017.
- Perkins Capital Management's portfolio value fell 7% quarter-over-quarter to $90.2M.
Based on Perkins Capital Management's 13F filing for Q2 2017, filed 26 Jul 2017.